NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ALKS - Alkermes Inc

Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ALKShart

Alkermes Inc News


Research Analysts' Ratings Reiterations for May, 18th (ACAS, ADSK, ALKS, ATML ...
Junction Report - May 18, 2012
American Capital (NASDAQ: ACAS) had its “neutral” rating re-affirmed by analysts at Zacks. They now have a $9.50 price target on the stock.

Revenues Skyrocket at Merged Alkermes
Zacks.com - May 18, 2012
Alkermes (ALKS - Analyst Report) reported break-even earnings (including depreciation and stock-based compensation expenses) in the fourth quarter of fiscal 2012 (ended March 31, 2012).

Goldman Sachs Cuts Price Target on Alkermes (ALKS)
Junction Report - May 18, 2012
Analysts at Goldman Sachs (NYSE: GS) lowered their price target on shares of Alkermes (NASDAQ: ALKS) from $18.00 to $17.00 in a research report issued to clients and investors on Friday.
Goldman Sachs Reiterates Neutral Rating, Lowers PT for Alkermes - Benzinga

Equities Sector Coverage: Stocks Break Lower on Increased Fear and Disappointment
Equities.com - May 17, 2012
Initial Jobless Claims came in at 370000 still above the 350000 recessionary threshold. The Philly Fed Index came in well below estimates at -5.8 in May when a +7.0 reading was expected.

Healthcare Stocks: Rosetta Falls On Equity Offering (ROSG, ALKS, HGSI, DNDN, PBH)
Quest News - May 17, 2012
Rosetta Genomics Ltd (USA) (NASDAQ:ROSG) slipped 12.63% to $4.36 on a traded volume of 1.79 million shares. The Company has entered into definitive agreements to purchase an aggregate of 632057 ordinary shares at price of $3.50 per share in a ...

Healthcare Stocks: Rosetta Falls On Equity Offering (ROSG, ALKS, HGSI, DNDN, PBH)
Gaining Green - May 17, 2012
By Gaining Green Staff Rosetta Genomics Ltd (USA) (NASDAQ:ROSG) slipped 12.63% to $4.36 on a traded volume of 1.79 million shares.

Alkermes Loss Widens; Details Weak FY Sales Outlook; Stock Down - Update
NASDAQ - May 17, 2012
(RTTNews.com) - Biotechnology company Alkermes plc (ALKS), Thursday reported a wider-than-expected loss for the fourth quarter, hurt mostly on charges related to the acquisition of Elan Drug Technologies last September.
Alkermes (NASDAQ:ALKS) Posts Loss 4Q on Elan Deal, Revenue Jumps- ALKS, VRX ... - Junction Report

Quarterly Earnings Results: AAP, ALKS, BKE, BONT, CATO, CSC, DANG, DLTR, GLOG ...
Movie News Guide (blog) - May 17, 2012
Advance Auto Parts (AAP) announced its earnings results on Thursday. The company reported $1.79 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.82 by $0.03.

Morning News: WMT, CP, SHLD, BAC, A, HBC and AV in Focus
ValueWalk - May 17, 2012
By Abhijit Sen Every morning we put out a news report with the latest news in global stock markets, company news, and global economic news.

Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for ...
MarketWatch (press release) - May 17, 2012
Alkermes plc (NASDAQ:ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2012, and provided financial expectations for its fiscal year 2013, which will be the first full fiscal year of the combined company, ...

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>